glp-1 drugs and breast cancer Cancer: Science, Safety, and Solutions GLP-1 Receptor Agonists Show a

Semaglutide GLP-1 is worth it, as you deserve to look and feel your best

GLP-1 Drug Prescriptions Have Doubled in Recent Years, But Many Users Quit Soon After Starting Use of Ozempic, Wegovy, Mounjaro and other GLP-1 drugs has spiked in recent years due to their effectiveness promoting weight loss, but side effects often cause users to discontinue the treatment within the first year

Clinical trials show average weight loss of 10-20% of body weight over 68 weeks

GLP-1 protein expression was also detected in intestinal mucosal tissue

So, while the study found promising evidence against short-term cancer risk, it can't tell us whether patients might develop cancers in future